Synbias Co-Owns Cancer Drug IP, Can't Be Sued, Judge Rules

In an unusual case that required an interpretation of Ukrainian patent law to determine ownership of U.S. patents, a California federal judge has ruled that Synbias Pharma cannot be sued by Solux Corp. for infringing chemotherapy drug patents because more

  • Tags: